Xiaoping Ren

Prof. Dr. Xiaoping Ren

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Surgery
Verified
Journal Article
Closed access
YYYijie Ye
Yijie Ye
CKC-Yoon Kim
C-Yoon Kim
QMQing Miao
Qing Miao
XRXiaoping Ren
Xiaoping Ren

14 June 2017 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
SRShuai Ren
Shuai Ren
ZLZe‐Han Liu
Ze‐Han Liu
QWQiong Wu
Qiong Wu
KFKuang Fu
Kuang Fu
JWJun Wu
Jun Wu
XRXiaoping Ren
Xiaoping Ren

20 June 2015 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
XRXiaoping Ren
Xiaoping Ren
YYYi‐Jie Ye
Yi‐Jie Ye
PLPeng‐Wei Li
Peng‐Wei Li
ZSZi‐Long Shen
Zi‐Long Shen
KHKe‐Cheng Han
Ke‐Cheng Han
YSYang Song
Yang Song

1 May 2018 in Surgery
Verified
Journal Article
Closed access
ZLZehan Liu
Zehan Liu
SRShuai Ren
Shuai Ren
KFKuang Fu
Kuang Fu
QWQiong Wu
Qiong Wu
JWJun Wu
Jun Wu
XRXiaoping Ren
Xiaoping Ren

26 March 2019 in Surgical Neurology International
Verified
Journal Article
Open access
XRXiaoping Ren
Xiaoping Ren
CKC-Yoon Kim
C-Yoon Kim
SCSergio Canavero
Sergio Canavero
Despite decades of animal experimentation, human translation with cell grafts, conduits, and other strategies has failed to cure patients with chronic spinal cord injury (SCI). Recent data show that motor deficits due to spinal cord transection in animal models can be reversed by local application of fusogens, such as Polyethylene glycol (PEG). Results proved superior at short term over all other treatments deployed in animal studies, opening the way to human trials. In particular, removal of the injured spinal cord segment followed by PEG fusion of the two ends along with vertebral osteotomy to shorten the spine holds the promise for a cure in many cases.

26 March 2019 in Surgical Neurology International
Verified
Journal Article
Open access
SRShuai Ren
Shuai Ren
ZLZehan Liu
Zehan Liu
CKC-Yoon Kim
C-Yoon Kim
KFKuang Fu
Kuang Fu
QWQiong Wu
Qiong Wu
XRXiaoping Ren
Xiaoping Ren
Background: Our study shows that a membrane sealant/fiber fusogen polyethylene glycol (PEG) applied immediately on a sharp section of the spinal cord can mend the cord and lead to exceptional levels of motor recovery, with some animals almost normal. Materials and Methods: Before deploying such technology in man, long-term data in large mammals that exclude delayed complications (e.g., central pain), confirm the stability of motor recovery, and provide histological evidence of fiber regrowth are necessary. Here, we provide such evidence in dogs followed up over 6 months and in 2 cases up to 1 year along with imaging and histologic data. Results: We show that dogs whose dorsal cord has been fully transected recover locomotion after immediate treatment with a fusogen (PEG). No pain syndrome ensued over the long term. Diffusion tensor imaging magnetic resonance and histological, including immunohistochemical, data confirmed the re-establishment of anatomical continuity along with interfacial axonal sprouting. Conclusions: This study proves that a form of irreversible spinal cord injury (SCI) can effectively be treated and points out a way to treat SCI patients.